North Carolina Medicaid

Does North Carolina Medicaid cover Zepbound?

Quick answer · Weight Loss

North Carolina Medicaid covers Zepbound for weight loss with prior authorization on Medicaid.

  • Medicaid: Covered with requirements. BMI of 30 or higher

Last verified June 4, 2026. Policy effective August 1, 2024. Source: download. How we verify this data →

Check your card for your exact plan →

Zepbound for Weight Loss

What North Carolina Medicaid requires, by plan type. Open this indication on its own page →

Medicaid

Covered with requirements

What you need to qualify

  • Age 18 and older
  • BMI of 30 or higher
  • BMI of 27 or higher with a weight-related condition (HTN, T2DM, OSA, CVD, and dyslipidemia)
  • 6 months of a documented diet and exercise program

Qualification pathways

You can qualify through any one of these.

Adult (18+) — BMI ≥ 30

All of:

  • Age 18 or older
  • BMI ≥ 30 kg/m²
  • FDA approved for indication, age, weight, and does not exceed dosing limits
  • Preferred drug trial completed (3–6 months titration) unless contraindicated or meets non-preferred PDL PA criteria
  • Baseline weight and BMI documented within past 45 days on PA form
  • Beneficiary is new to therapy or attempting a repeat weight loss course
  • Currently on and will continue lifestyle modification (structured nutrition and physical activity)
  • Will NOT use in combination with another GLP-1 receptor agonist
  • No FDA-labeled contraindications (including pregnancy, lactation, medullary thyroid cancer history, MEN2)

Adult (18+) — BMI ≥ 27 with comorbidity

All of:

  • Age 18 or older
  • BMI ≥ 27 kg/m²
  • At least one weight-related comorbidity/risk factor/complication (hypertension, type 2 diabetes, obstructive sleep apnea, cardiovascular disease, dyslipidemia)
  • FDA approved for indication, age, weight, and does not exceed dosing limits
  • Preferred drug trial completed (3–6 months titration) unless contraindicated or meets non-preferred PDL PA criteria
  • Baseline weight and BMI documented within past 45 days on PA form
  • Beneficiary is new to therapy or attempting a repeat weight loss course
  • Currently on and will continue lifestyle modification (structured nutrition and physical activity)
  • Will NOT use in combination with another GLP-1 receptor agonist
  • No FDA-labeled contraindications (including pregnancy, lactation, medullary thyroid cancer history, MEN2)

Documentation to bring

  • Baseline weight and BMI (measured within the past 45 days) documented on PA form
  • Documentation of preferred drug trial (3–6 months titration) or documented contraindication to preferred drug
  • Documentation that beneficiary is new to therapy or attempting a repeat weight loss course
  • For BMI ≥ 27 with comorbidity pathway: documentation of qualifying weight-related comorbidity

Quantity limits

  • all strengths — 2 mL per 28 days

Approval and renewal

  • Initial approval: 6 months
  • Renewal: every 12 months
  • To renew, the plan looks for at least 5% weight loss from the starting weight, at least 4% reduction in BMI, and Adults: 5% total pretreatment weight loss maintained. Adolescents (12 to <18): >4% reduction in baseline BMI maintained. Alternatively, documented weight loss deemed significant per prescriber even if thresholds not met (with rationale). Continued lifestyle modification required. No combination with another GLP-1. No FDA-labeled contraindications. At each renewal, provider must document review of medication list for possible dose reductions or discontinuation of comorbid medications no longer needed due to weight reduction effects. Note: Zepbound for weight loss is only approved for adults (18+). Make sure your starting weight and date are in the chart now — renewal is measured against it.

Not covered when

  • Lactation
  • History of medullary thyroid carcinoma
  • Multiple endocrine neoplasia syndrome type 2 (MEN2)
  • Concurrent use with another GLP-1 receptor agonist
  • Patients under 18 years of age (Zepbound is 18 and over only)
  • Pregnancy

Policy note: Zepbound for weight loss is restricted to adults 18 and over, unlike Wegovy which has a lower age limit of 12. The general weight management policy also allows adults ≥ 45 with BMI ≥ 27 and established CVD (MI, stroke, symptomatic peripheral disease) as a qualifying pathway. Renewal duration is 12 months per the general weight management renewal section.

Policy effective August 1, 2024 · verified June 4, 2026 · source: download

Zepbound for Osa

What North Carolina Medicaid requires, by plan type. Open this indication on its own page →

Medicaid

Covered with requirements

What you need to qualify

  • Age 18 and older
  • BMI of 30 or higher
  • 6 months of a documented diet and exercise program
  • Diagnosed obstructive sleep apnea

Qualification pathways

You can qualify through any one of these.

Moderate to Severe OSA in Adult with Obesity

All of:

  • Diagnosis of moderate to severe obstructive sleep apnea (OSA) — confirmed by sleep apnea testing (documentation required with PA request)
  • Adult (18 years of age or over)
  • Documented baseline BMI > 30 kg/m² prior to beginning therapy
  • Obesity as a comorbid condition
  • Beneficiary instructed on sleep hygiene modifications before beginning Zepbound (sleep positioning, avoidance of alcohol and stimulants before bed)
  • FDA approved for indication, age, weight, and does not exceed dosing limits
  • Currently on and will continue lifestyle modification (structured nutrition and physical activity)
  • Will NOT use in combination with another GLP-1 receptor agonist
  • No FDA-labeled contraindications (including pregnancy, lactation, medullary thyroid cancer history, MEN2)

Documentation to bring

  • Documentation confirming sleep apnea testing was performed and moderate to severe OSA was diagnosed (must be submitted with PA request)
  • Documented baseline BMI > 30 kg/m² prior to beginning therapy
  • Documentation that beneficiary was instructed on sleep hygiene modifications before beginning Zepbound

Quantity limits

  • all strengths — 2 mL per 28 days

Approval and renewal

  • Initial approval: 6 months
  • Renewal: every 6 months
  • To renew, the plan looks for Medical documentation that beneficiary has improved while on medication AND individual clinical goals set by provider are being met OR beneficiary is continuing to make adequate progress towards treatment goals. Continued lifestyle modification required. No combination with another GLP-1. No FDA-labeled contraindications. Provider must document review of medication list at each renewal for possible dose reductions or discontinuation of comorbid medications. Note: Covered indication went into effect October 1, 2025; prior PA approval through Medicaid required before renewal.

Not covered when

  • Lactation
  • History of medullary thyroid carcinoma
  • Multiple endocrine neoplasia syndrome type 2 (MEN2)
  • Concurrent use with another GLP-1 receptor agonist
  • Patients under 18 years of age
  • Pregnancy

Policy note: Policy requires documentation of moderate to severe OSA via sleep apnea testing submitted with PA request. The policy specifies 'moderate to severe' OSA but does not provide a numeric AHI threshold; AHI classification is per standard sleep medicine criteria. Policy does not explicitly require a prior PAP/CPAP trial for Zepbound OSA indication. Sleep hygiene instruction prior to therapy is required. Covered indication went into effect October 1, 2025 per the renewal criteria section. Duration of approval is 6 months for both initial and renewals for the OSA indication.

Policy effective August 1, 2024 · verified June 4, 2026 · source: download

Why Zepbound requests get denied by North Carolina Medicaid

Based on what this policy asks for. Fix these before the first submission.

  1. Wrong brand for the diagnosis. Zepbound and Mounjaro are the same molecule with different approved uses; a request for Zepbound under a diagnosis that matches Mounjaro is routinely denied.
  2. BMI not documented in the chart notes (or documented without a baseline weight and date).
  3. Qualifying weight-related condition not documented with its own diagnosis code.
  4. No documented diet and exercise program.
  5. Baseline weight wasn't recorded at the start, so the required weight loss can't be shown at renewal.

Frequently asked questions

Does North Carolina Medicaid cover Zepbound?
North Carolina Medicaid covers Zepbound for weight loss with prior authorization on Medicaid.
What BMI do you need for Zepbound under North Carolina Medicaid?
For weight loss on Medicaid plans, North Carolina Medicaid requires a BMI of 30 or higher, or 27 or higher with a qualifying weight-related condition.
How long does a Zepbound approval last with North Carolina Medicaid?
Initial approvals last 6 months, and renewals are granted in 12-month periods.
What does North Carolina Medicaid require to renew Zepbound?
At least 5% weight loss from the starting weight, at least 4% reduction in BMI, and Adults: 5% total pretreatment weight loss maintained. Adolescents (12 to <18): >4% reduction in baseline BMI maintained. Alternatively, documented weight loss deemed significant per prescriber even if thresholds not met (with rationale). Continued lifestyle modification required. No combination with another GLP-1. No FDA-labeled contraindications. At each renewal, provider must document review of medication list for possible dose reductions or discontinuation of comorbid medications no longer needed due to weight reduction effects. Note: Zepbound for weight loss is only approved for adults (18+).
How current is this information?
This page reflects North Carolina Medicaid's written policy as of August 1, 2024, last verified against the source document on June 4, 2026.

Other medications under North Carolina Medicaid

Zepbound coverage under other plans

All insurance plans · All medications

This page summarizes North Carolina Medicaid's written prior-authorization policy. It is not a guarantee of coverage; plans vary by employer and benefit design. Verify with your plan before relying on it.